Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 43-47

  Iizuka, Norio ^a   Mori, Naohide ^a   Tamesa, Takuo ^a   Tangoku, Akira ^a   Oka, Masaaki ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; nm23; Nucleoside diphosphate kinase; Telomerase

Indexed keywords

TELOMERASE;

ARTICLE; CELL IMMORTALIZATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TRANSACTIVATION;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; TELOMERASE; TRANSCRIPTION FACTORS;

EID: 0037233775     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S and Hamamoto Y: Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 62: 3939-3944, 2002.
2. Tahara H, Nakanishi T, Kitamoto M, Nakashio I, Shay JW, Tahara E, Kajiyama G and Ide T: Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736, 1995.
3. Kojima H, Yokosuka O, Imazeki F, Saisho HI and Omata M: Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 112: 493-500, 1997.
4. Huang GT, Lee HS, Chen CH, Chiou LL, Lin YW, Lee CZ, Chen DS and Sheu JC: Telomerase activity and telomere length in human hepatocellular carcinoma. Eur J Cancer 34: 1946-1949, 1998.
5. Thorgeirsson SS and Grisham JW: Molecular pathogenesis of human hepatocellular carcinoma. Nature Genet 31: 339-346, 2002.
6. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J and Dalla-Favera R: Direct activation of TERT transcription by c-MYC. Nature Genet 21: 220-224, 1999.
7. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H and Inoue M: Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 28: 669-77, 2000.
8. Stahl JA, Leone A, Rosengard AM, Potter L, King CR and Steeg PS: Identification of a second human nm23 gene, nm23-H2. Cancer Res 51: 445-449, 1991.
9. Berberich SJ and Postel EH: PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element. Oncogene 10: 2343-2347, 1995.
10. Postel EH: Cleavage of DNA by human NM23-H2/nucleoside diphosphate kinase involves formation of a covalent protein-DNA complex. J Biol Chem 274: 22821-22829, 1999.
11. Nosaka K, Kawahara M, Masuda M, Satomi Y and Nishino, H: Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. Biochem Biophys Res Commun 243: 342-348, 1998.
12. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA and Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
13. Gunduz M, Ayhan A, Gullu 1, Onerci M, Hosal AS, Gursel B, Hosal IN and Firat D: nm23 Protein expression in larynx cancer and the relationship with metastasis. Eur J Cancer 33: 2338-2341, 1997.
14. Iizuka N, Tangoku A, Hazama S, Yoshino S, Mori N and Oka M: Nm23-H1 gene as a molecular switch between the free-floating and adherent states of gastric cancer cells. Cancer Lett 174: 65-71, 2001.
15. Ferguson AW, Flatow U, MacDonald NJ, Larminat F, Bohr VA and Steeg PS: Increased sensitivity to cisplatin by nm23-transfected tumor cell lines. Cancer Res 56: 2931-2935, 1996.
16. Iizuka N, Hirose K, Noma T, Hazama S, Tangoku A, Hayashi H, Abe T, Yamamoto K and Oka M: The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. Br J Cancer 81: 469-475, 1999.
17. Iizuka N, Miyamoto K, Tangoku A, Hayashi H, Hazama S, Yoshino, S, Yoshimura K, Hirose K, Yoshida H and Oka M: Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase. Br J Cancer 83: 1209-1215, 2000.
18. Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K and Suzuki T: NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res 55: 652-657, 1995.
19. Mori N, Oka M, Hazama S, Iizuka N, Yamamoto K, Yoshino S, Tangoku A, Noma T and Hirose K: Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads. Br J Cancer 83: 1026-1032, 2000.
20. Nouso K, Urabe Y, Higashi T, Nakatsukasa H, Hino N, Ashida K, Kinugasa N, Yoshida K, Uematsu S and Tsuji T: Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 78: 232-236, 1996.
21. Kim SH, Kaminker P and Campisi J: TIN2, a new regulator of telomere length in human cells. Nature Genet 23: 405-412, 1999.
22. Kawate S, Fukusato T, Ohwada S, Watanuki A and Morishita Y: Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 over-expression. Oncology 57: 157-163, 1999.
23. Liu P, Terradillos O, Renard CA, Feldmann G, Buendia MA and Bernuau D: Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II. Hepatology 25: 874-883, 1997.
24. Yamaguchi A, Urano T, Goi T, Takeuchi K, Niimoto S, Nakagawara G, Furukawa K and Shiku H: Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer 73: 2280-2284, 1994.
25. Boix L, Bruix J, Campo E, Sole M, Castells A, Fuster J, Rivera F, Cardesa A and Rodes J: Nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology 107: 486-491, 1994.
26. Suda T, Isokawa, O, Aoyagi Y, Nomoto M, Tsukada K, Shimizu T, Suzuki Y, Naito A, Igarashi H, Yanagi M, Takahashi T and Asakura H: Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver. Hepatology 27: 402-406, 1998.